Your browser doesn't support javascript.
loading
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
Panhaleux, Marion; Espitia, Olivier; Terrier, Benjamin; Manson, Guillaume; Maria, Alexandre; Humbert, Sébastien; Godbert, Benoît; Perrin, Julie; Achille, Aurélie; Arrondeau, Jennifer; Kostine, Marie; Fallet, Vincent; Pugnet, Grégory; Chaigne, Benjamin; Champiat, Stéphane; Laparra, Ariane; Danlos, Francois-Xavier; Launay, David; Penel, Nicolas; Lambotte, Olivier; Michot, Jean-Marie; Forestier, Alexandra.
Afiliação
  • Panhaleux M; Faculté de Médecine, Université de Lille, France. Electronic address: m.panhaleux@gmail.com.
  • Espitia O; Internal Medicine Department, Hôtel-Dieu, Nantes University Hospital, University of Nantes, Nantes, France.
  • Terrier B; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, APHP, University of Paris, Paris, France.
  • Manson G; Department of Hematology, University Hospital of Rennes, Rennes, France.
  • Maria A; Department of Internal Medicine and Multiorgan Diseases, Referral Center for Auto-immune Diseases, Saint-Eloi Hospital Montpellier University, Montpellier, France.
  • Humbert S; Department of Internal Medicine, CHU, Besançon, France.
  • Godbert B; Department of Pneumology, Robert Schuman Hospital, Metz, France.
  • Perrin J; Department of Pneumology, Robert Schuman Hospital, Metz, France.
  • Achille A; Internal Medicine Department, Hôtel-Dieu, Nantes University Hospital, University of Nantes, Nantes, France.
  • Arrondeau J; Department of Medical Oncology, APHP, Hôpital Cochin, Paris, France.
  • Kostine M; Department of Rheumatology, University Hospital of Bordeaux, Bordeaux, France.
  • Fallet V; Department of Pneumology, Hôpital Tenon, Sorbonne University, Paris, France.
  • Pugnet G; Department of Internal Medicine, Centre Hospitalier Universitaire, Toulouse, France.
  • Chaigne B; Department of Internal Medicine, APHP, Hôpital Cochin, Paris Descartes University, Paris, France.
  • Champiat S; Drug Development Department (DITEP), Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
  • Laparra A; Drug Development Department (DITEP), Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
  • Danlos FX; Drug Development Department (DITEP), Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
  • Launay D; Internal Medicine and Clinical Immunology Department, Univ. Lille, CHU Lille, Inserm, Centre de Référence des Maladies Autoimmunes Systémiques Rares Du Nord et Nord-Ouest de France (CeRAINO), U1286, INFINITE, Institute for Translational Research in Inflammation, 59000 Lille, France.
  • Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille University, Lille, France.
  • Lambotte O; Internal Medicine and Clinical Immunology Department, APHP, University Hospital Bicêtre, Paris Sud 11 University, Le Kremlin Bicêtre, France.
  • Michot JM; Drug Development Department (DITEP), Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
  • Forestier A; Department of Medical Oncology, Centre Oscar Lambret, Lille University, Lille, France.
Eur J Cancer ; 160: 134-139, 2022 01.
Article em En | MEDLINE | ID: mdl-34810048
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Receptor de Morte Celular Programada 1 / Imunoterapia Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Receptor de Morte Celular Programada 1 / Imunoterapia Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article